These data are consistent with the reports of others demonstrating that MMP-9 is one of the key mediators of tumor cell invasion [11,12,33] and supports the idea of the DNAzyme gene-targeted approach for MMP-9 as a breast cancer therapeutic agent. The gene discussed is MMP9; the disease is breast carcinoma.